Single Infrapubic Versus Bilateral Subinguinal Microsurgical Varicocelectomy
1 other identifier
interventional
40
1 country
1
Brief Summary
Bilateral varicocele is commonly treated by microsurgical varicocelectomy. The conventional bilateral subinguinal approach usually requires two separate skin incisions, one on each side. A single midline infrapubic approach may allow bilateral microsurgical repair through one incision and may reduce access-related morbidity. This prospective randomized controlled trial will compare single infrapubic microsurgical bilateral varicocelectomy with conventional bilateral subinguinal microsurgical varicocelectomy in adult men with clinically palpable bilateral varicocele. The study will evaluate postoperative pain, analgesic requirement, time to return to normal daily activity, operative time, scar satisfaction, wound complications, recurrence, and other safety outcomes during follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2026
CompletedFirst Submitted
Initial submission to the registry
June 11, 2026
CompletedFirst Posted
Study publicly available on registry
June 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
June 16, 2026
June 1, 2026
10 months
June 11, 2026
June 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Postoperative Pain Score
Postoperative pain will be assessed using the Visual Analog Scale. The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate worse postoperative pain.
6 hours, 24 hours, and 7 days after surgery
Analgesic Requirement
Analgesic requirement will be assessed by recording the total number and dose of analgesic tablets and/or injections consumed by the participant during the first 7 postoperative days. Higher analgesic use indicates greater postoperative analgesic requirement.
During the first 7 postoperative days
Time to Return to Normal Daily Activity
Time to return to normal daily activity will be defined as the number of days from surgery until the participant resumes usual non-strenuous daily activities. A shorter time indicates faster postoperative recovery.
From surgery until return to normal daily activity, assessed up to 30 days after surgery
Total Operative Time
Total operative time will be defined as the time from skin incision to completion of skin closure, measured in minutes.
During surgery
Secondary Outcomes (4)
Scar Satisfaction and Cosmetic Outcome
6 months after surgery
Varicocele Recurrence
6 months after surgery
Conversion or Access Failure
During surgery
Wound Complications
Up to 30 days after surgery
Study Arms (2)
Single Infrapubic Microsurgical Bilateral Varicocelectomy
EXPERIMENTALParticipants allocated to this arm will undergo bilateral microsurgical varicocelectomy through a single midline infrapubic skin incision. The right and left spermatic cords will be approached sequentially through the same incision under microscopic or high-magnification surgical loupes with microsurgical capability. Dilated spermatic veins will be ligated while preserving the testicular artery or arteries, lymphatic vessels, vas deferens, and vasal vessels.
Bilateral Subinguinal Microsurgical Varicocelectomy
ACTIVE COMPARATORParticipants allocated to this arm will undergo conventional bilateral subinguinal microsurgical varicocelectomy through two separate standard subinguinal incisions, one on each side. Each spermatic cord will be isolated at the subinguinal level under microscopic or high-magnification surgical loupes with microsurgical capability. Dilated spermatic veins will be ligated while preserving the testicular artery or arteries, lymphatic vessels, vas deferens, and vasal vessels.
Interventions
Conventional bilateral microsurgical varicocelectomy performed through two separate standard subinguinal incisions, one on each side. Each spermatic cord will be isolated at the subinguinal level under microscopic or high-magnification surgical loupes with microsurgical capability. Dilated spermatic veins will be ligated while preserving the testicular artery or arteries, lymphatic vessels, vas deferens, and vasal vessels.
Bilateral microsurgical varicocelectomy performed through a single midline infrapubic skin incision. The right and left spermatic cords will be approached sequentially through the same incision under microscopic or high-magnification surgical loupes with microsurgical capability. Dilated spermatic veins will be ligated while preserving the testicular artery or arteries, lymphatic vessels, vas deferens, and vasal vessels.
Eligibility Criteria
You may qualify if:
- Male patients aged 18 to 45 years.
- Clinically palpable bilateral varicocele, grade II or grade III.
- Diagnosis confirmed by color Doppler ultrasound.
- Infertility for at least 12 months and/or abnormal semen analysis.
- Female partner evaluation performed or planned to exclude major uncorrected female-factor infertility.
- Patient fit for surgery and anesthesia.
- Written informed consent provided by the participant.
You may not qualify if:
- Subclinical varicocele detected only by Doppler ultrasound.
- Unilateral varicocele.
- Recurrent varicocele after previous surgery, embolization, or sclerotherapy.
- Previous inguinal, scrotal, pelvic, or penile surgery likely to distort surgical anatomy.
- Associated inguinal hernia, hydrocele, spermatocele, epididymal cyst, or other scrotal condition requiring simultaneous surgery.
- Azoospermia, especially suspected non-obstructive azoospermia.
- Active urinary tract or genital infection.
- Coagulopathy or anticoagulant therapy that cannot be safely interrupted.
- Severe obesity, defined as body mass index greater than 40 kg/m², or any anatomical condition preventing safe exposure by either surgical approach.
- Refusal to participate or inability to complete follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Urology- Beni-Suef University Hospitals
Banī Suwayf, Beni Suweif Governorate, 02456, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hany F Badawy, MD
Faculty of medicine Beni-Suef University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This is an open-label surgical trial. Participant and surgeon blinding is not feasible because the incision site and number of incisions differ between the two surgical approaches. Semen analysis will be performed by laboratory staff blinded to treatment allocation, and statistical analysis will be performed using coded groups.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Urology, Faculty of Medicine, Beni-Suef University
Study Record Dates
First Submitted
June 11, 2026
First Posted
June 16, 2026
Study Start
June 8, 2026
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
June 16, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the study includes sensitive reproductive health data, semen analysis results, infertility-related information, and treatment-related clinical information. Only aggregated, de-identified results will be reported in publications or presentations. Any future sharing of de-identified participant-level data would require additional approval from the Research Ethics Committee, Faculty of Medicine, Beni-Suef University.